About PreventionGenetics
PreventionGenetics is a company based in Marshfield (United States) founded in 2004 by James Weber was acquired by Exact Sciences in January 2022. The company has 205 employees as of December 31, 2022. PreventionGenetics offers products and services including PGnome, PGxome, PGmax, and Custom Panels. PreventionGenetics operates in a competitive market with competitors including Omniome, Novogene Corporation, Tessera Therapeutics, Phase Genomics and HitGen, among others.
- Headquarter Marshfield, United States
- Employees 205 as on 31 Dec, 2022
- Founders James Weber
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Preventiongenetics, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
205
as on Dec 31, 2022
-
Acquired by
Exact Sciences
(Jan 09, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PreventionGenetics
PreventionGenetics offers a comprehensive portfolio of products and services, including PGnome, PGxome, PGmax, and Custom Panels.
Comprehensive DNA testing for clinical genetic diagnosis.
Advanced genetic testing for identifying variants.
Tailored DNA tests for specific genetic disorders.
Specialized panels for various disease categories.
People of PreventionGenetics
Unlock access to complete
Unlock access to complete
Leadership Team
105 people
Software Development Team
103 people
Screening Team
78 people
Senior Team
62 people
Sales and Marketing
30 people
Data Analysis and Operations Team
29 people
Human Resources and Administration
28 people
Operations Team
23 people
Unlock access to complete
Funding Insights of PreventionGenetics
Investors in PreventionGenetics
PreventionGenetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-invasive molecular diagnostic tests for cancer detection are provided.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PreventionGenetics
Financial Statements - PreventionGenetics
Preventiongenetics Comparisons
Competitors of PreventionGenetics
PreventionGenetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Tessera Therapeutics, Phase Genomics and HitGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
New genome engineering technology is provided for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Next-generation gene sequencing and multi-omics technologies are provided.
|
Latest news on Preventiongenetics
Frequently Asked Questions about PreventionGenetics
PreventionGenetics was founded in 2004.
PreventionGenetics is headquartered in Marshfield, United States. It is registered at Marshfield, Wisconsin, United States.
James Weber is the current CEO of PreventionGenetics. They have also founded this company.
As of Dec 31, 2022, the latest employee count at PreventionGenetics is 205.
PreventionGenetics was founded in 2004 in Marshfield, United States. Sequencing services and duplication tests for clinical genes are offered within the genetic diagnostics sector. Whole-exome sequencing tests are performed using the PGxome platform. DNA banking is facilitated through the PGDNA bank. Additional tests, including KATNB1 Gene Sequencing and the Parkinson Disease and Parkinsonism Sequencing Panel, are available to support clinical applications.
PreventionGenetics's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.
PreventionGenetics offers PGnome, PGxome, PGmax, and Custom Panels.
PreventionGenetics has 1 investor. Key investors include Exact Sciences.